2020
DOI: 10.1016/j.annonc.2020.04.381
|View full text |Cite
|
Sign up to set email alerts
|

P-299 Cytoreductive surgery with gastrectomy and HIPEC for gastric cancer with limited peritoneal metastases treated with neoadjuvant systemic therapy is feasible and safe

Abstract: Conclusion: Patients achieving pCR and younger age had better OS and DFS. Compliance with treatment was 60%, largely affected by financial constraints in a resource-limited setting which emphasizes the importance of multidisciplinary clinics and cautious patient selection.Legal entity responsible for the study: The authors.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles